Status:
COMPLETED
Comparison Study of Sentinel Lymph Node Biopsy by Multimodal Method in Breast Cancer
Lead Sponsor:
National Cancer Center, Korea
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
20+ years
Phase:
PHASE2
Brief Summary
Sentinel lymph node biopsy (SLNB) has become a mainstay surgery method in breast cancer. It provides the surgeon the evidence of axillary lymph node metastasis, which determines the extent of surgery....
Detailed Description
Indocyanine green Advantages: provides visualization of sentinel lymph node without incision Blue dye Advantages: easy to employ; no toxicity Disadvantages: diffusion; absorption and disappearance of...
Eligibility Criteria
Inclusion
- clinically lymph node negative breast cancer patients
- consented patients with more than 20 years
Exclusion
- history of breast cancer
- locally advanced breast cancer and metastatic breast cancer
- proven axillary lymph node metastasis
- history of axillary excisional or incisional biopsy, or dissection
- history of neoadjuvant chemotherapy
- pregnancy
- non-consented patients
- younger than 20 years old
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT01856452
Start Date
September 1 2011
End Date
October 1 2012
Last Update
May 17 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Center
Goyang-si, Gyeonggi-do, South Korea, 410-769